Concepts (310)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Penis | 31 | 2018 | 72 | 6.440 |
Why?
|
Penile Induration | 16 | 2014 | 19 | 3.970 |
Why?
|
Stem Cells | 11 | 2020 | 132 | 3.220 |
Why?
|
Erectile Dysfunction | 9 | 2018 | 26 | 2.760 |
Why?
|
Stem Cell Transplantation | 6 | 2019 | 31 | 2.510 |
Why?
|
Phosphodiesterase Inhibitors | 10 | 2012 | 30 | 2.420 |
Why?
|
Transforming Growth Factor beta | 15 | 2008 | 183 | 2.300 |
Why?
|
Muscle, Skeletal | 14 | 2013 | 257 | 2.230 |
Why?
|
Fibrosis | 19 | 2011 | 146 | 2.040 |
Why?
|
Impotence, Vasculogenic | 6 | 2012 | 11 | 2.040 |
Why?
|
Nitric Oxide Synthase | 13 | 2010 | 103 | 1.990 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2018 | 87 | 1.940 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2020 | 592 | 1.780 |
Why?
|
Rats | 33 | 2020 | 3261 | 1.580 |
Why?
|
Dyslipidemias | 2 | 2019 | 42 | 1.350 |
Why?
|
Piperazines | 6 | 2012 | 109 | 1.280 |
Why?
|
Transforming Growth Factor beta1 | 9 | 2014 | 91 | 1.270 |
Why?
|
Animals | 52 | 2020 | 14307 | 1.170 |
Why?
|
Sulfones | 6 | 2012 | 40 | 1.080 |
Why?
|
Rats, Zucker | 8 | 2020 | 22 | 1.030 |
Why?
|
Myostatin | 12 | 2013 | 57 | 1.020 |
Why?
|
Rats, Inbred F344 | 14 | 2013 | 228 | 1.010 |
Why?
|
Thiazolidinediones | 3 | 2010 | 48 | 1.010 |
Why?
|
Ethanol | 2 | 2016 | 188 | 1.000 |
Why?
|
Male | 55 | 2019 | 18870 | 1.000 |
Why?
|
Penile Erection | 7 | 2013 | 18 | 0.910 |
Why?
|
Muscle, Smooth | 9 | 2015 | 51 | 0.860 |
Why?
|
Muscle Fibers, Skeletal | 3 | 2013 | 60 | 0.770 |
Why?
|
Urinary Incontinence, Stress | 1 | 2020 | 1 | 0.770 |
Why?
|
Palmitic Acid | 1 | 2020 | 24 | 0.760 |
Why?
|
Apoptosis | 11 | 2020 | 1317 | 0.740 |
Why?
|
Cell Differentiation | 11 | 2018 | 562 | 0.740 |
Why?
|
Blotting, Western | 13 | 2009 | 834 | 0.730 |
Why?
|
Obesity | 3 | 2020 | 965 | 0.730 |
Why?
|
Kidney Tubules | 2 | 2010 | 28 | 0.720 |
Why?
|
Myocytes, Smooth Muscle | 5 | 2016 | 84 | 0.720 |
Why?
|
Urinary Incontinence | 1 | 2019 | 15 | 0.710 |
Why?
|
Cholesterol | 1 | 2020 | 194 | 0.690 |
Why?
|
Immunohistochemistry | 12 | 2013 | 859 | 0.670 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2011 | 91 | 0.660 |
Why?
|
Hypoglycemic Agents | 3 | 2010 | 152 | 0.650 |
Why?
|
Vagina | 3 | 2009 | 81 | 0.640 |
Why?
|
Oxidative Stress | 8 | 2015 | 874 | 0.610 |
Why?
|
Carbolines | 2 | 2007 | 13 | 0.590 |
Why?
|
Fibroblasts | 6 | 2009 | 252 | 0.580 |
Why?
|
Mesoderm | 2 | 2008 | 70 | 0.580 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 65 | 0.580 |
Why?
|
RNA, Small Interfering | 3 | 2008 | 391 | 0.580 |
Why?
|
Muscle Development | 3 | 2013 | 44 | 0.560 |
Why?
|
Molsidomine | 2 | 2012 | 4 | 0.550 |
Why?
|
Gene Transfer Techniques | 2 | 2006 | 43 | 0.530 |
Why?
|
Mice | 18 | 2013 | 5668 | 0.530 |
Why?
|
Collagen | 5 | 2014 | 162 | 0.530 |
Why?
|
Breast | 1 | 2016 | 134 | 0.510 |
Why?
|
Aging | 8 | 2015 | 639 | 0.500 |
Why?
|
Testosterone | 6 | 2015 | 181 | 0.490 |
Why?
|
Myoblasts | 3 | 2009 | 25 | 0.470 |
Why?
|
Cells, Cultured | 7 | 2020 | 1442 | 0.470 |
Why?
|
Benzhydryl Compounds | 1 | 2013 | 42 | 0.460 |
Why?
|
Endocrine Disruptors | 1 | 2013 | 38 | 0.460 |
Why?
|
Muscle Denervation | 1 | 2012 | 4 | 0.450 |
Why?
|
Receptors, Androgen | 5 | 2005 | 122 | 0.450 |
Why?
|
Phenols | 1 | 2013 | 76 | 0.450 |
Why?
|
Epithelial Cells | 1 | 2016 | 366 | 0.450 |
Why?
|
Vasodilator Agents | 1 | 2012 | 54 | 0.440 |
Why?
|
Gene Expression | 7 | 2007 | 639 | 0.440 |
Why?
|
Disease Models, Animal | 5 | 2020 | 1300 | 0.410 |
Why?
|
Antifibrinolytic Agents | 1 | 2010 | 3 | 0.400 |
Why?
|
Multipotent Stem Cells | 2 | 2008 | 16 | 0.390 |
Why?
|
Adipocytes | 3 | 2005 | 54 | 0.380 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2010 | 5 | 0.380 |
Why?
|
Diabetic Nephropathies | 1 | 2010 | 53 | 0.370 |
Why?
|
Myocardium | 1 | 2012 | 224 | 0.370 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 70 | 0.370 |
Why?
|
Gene Expression Regulation | 7 | 2016 | 968 | 0.370 |
Why?
|
Myocardial Infarction | 1 | 2012 | 221 | 0.360 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 24 | 0.350 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 8 | 2007 | 605 | 0.350 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2009 | 6 | 0.350 |
Why?
|
DNA, Complementary | 3 | 2004 | 175 | 0.350 |
Why?
|
Humans | 29 | 2018 | 34853 | 0.350 |
Why?
|
Penile Diseases | 1 | 2009 | 8 | 0.350 |
Why?
|
Purines | 4 | 2012 | 37 | 0.350 |
Why?
|
Tunica Media | 1 | 2009 | 14 | 0.350 |
Why?
|
Peripheral Nerves | 1 | 2008 | 14 | 0.340 |
Why?
|
Breast Neoplasms | 2 | 2016 | 1426 | 0.340 |
Why?
|
Imidazoles | 2 | 2006 | 124 | 0.340 |
Why?
|
Cell Line | 6 | 2016 | 1289 | 0.340 |
Why?
|
Nitric Oxide Synthase Type I | 6 | 2013 | 51 | 0.330 |
Why?
|
Antioxidants | 1 | 2011 | 386 | 0.320 |
Why?
|
Aorta | 1 | 2009 | 161 | 0.320 |
Why?
|
RNA, Messenger | 9 | 2014 | 1152 | 0.320 |
Why?
|
Prostatectomy | 1 | 2007 | 56 | 0.300 |
Why?
|
PPAR gamma | 1 | 2007 | 49 | 0.300 |
Why?
|
Arginine | 2 | 2006 | 62 | 0.300 |
Why?
|
Pluripotent Stem Cells | 2 | 2003 | 31 | 0.300 |
Why?
|
Acetaldehyde | 2 | 2016 | 10 | 0.290 |
Why?
|
Diabetic Angiopathies | 1 | 2006 | 20 | 0.290 |
Why?
|
Muscular Atrophy | 2 | 2003 | 12 | 0.290 |
Why?
|
Priapism | 1 | 2006 | 2 | 0.280 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2006 | 22 | 0.280 |
Why?
|
Muscle Proteins | 2 | 2003 | 48 | 0.280 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 6 | 0.280 |
Why?
|
Myocytes, Cardiac | 1 | 2007 | 165 | 0.260 |
Why?
|
Mice, Knockout | 3 | 2013 | 897 | 0.250 |
Why?
|
Recombinant Proteins | 4 | 2008 | 485 | 0.250 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2003 | 19 | 0.240 |
Why?
|
Female | 10 | 2020 | 19873 | 0.240 |
Why?
|
Signal Transduction | 8 | 2015 | 1802 | 0.230 |
Why?
|
Aromatase | 1 | 2003 | 19 | 0.230 |
Why?
|
Rats, Sprague-Dawley | 5 | 2008 | 1534 | 0.230 |
Why?
|
Endothelium | 2 | 2016 | 31 | 0.230 |
Why?
|
Space Flight | 1 | 2002 | 9 | 0.230 |
Why?
|
Menopause | 1 | 2003 | 54 | 0.230 |
Why?
|
Weightlessness | 1 | 2002 | 14 | 0.220 |
Why?
|
Body Composition | 1 | 2003 | 146 | 0.220 |
Why?
|
Cell Proliferation | 3 | 2016 | 1149 | 0.220 |
Why?
|
Myosin Heavy Chains | 1 | 2002 | 19 | 0.210 |
Why?
|
Nitric Oxide | 5 | 2015 | 287 | 0.210 |
Why?
|
Immediate-Early Proteins | 1 | 2002 | 45 | 0.210 |
Why?
|
Endothelium, Vascular | 2 | 2015 | 229 | 0.210 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 396 | 0.200 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 984 | 0.190 |
Why?
|
Actins | 3 | 2010 | 142 | 0.190 |
Why?
|
Electroporation | 3 | 2006 | 18 | 0.180 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 298 | 0.180 |
Why?
|
Repressor Proteins | 1 | 2002 | 226 | 0.180 |
Why?
|
In Situ Nick-End Labeling | 2 | 2010 | 126 | 0.180 |
Why?
|
Genetic Vectors | 3 | 2006 | 154 | 0.180 |
Why?
|
Plasmids | 3 | 2006 | 233 | 0.170 |
Why?
|
Transcription Factors | 3 | 2013 | 653 | 0.170 |
Why?
|
Mice, Inbred C57BL | 3 | 2013 | 1530 | 0.160 |
Why?
|
Mice, Inbred BALB C | 2 | 2013 | 649 | 0.150 |
Why?
|
Organ Size | 3 | 2007 | 148 | 0.150 |
Why?
|
Phenotype | 2 | 2009 | 650 | 0.140 |
Why?
|
Transfection | 2 | 2007 | 496 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2009 | 127 | 0.140 |
Why?
|
Mice, Inbred C3H | 3 | 2005 | 83 | 0.130 |
Why?
|
Pentoxifylline | 2 | 2006 | 6 | 0.130 |
Why?
|
Estrogens | 1 | 2016 | 190 | 0.130 |
Why?
|
Metalloproteases | 1 | 2014 | 16 | 0.130 |
Why?
|
Cyclic GMP | 2 | 2006 | 44 | 0.130 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 203 | 0.130 |
Why?
|
Transcription, Genetic | 2 | 2016 | 550 | 0.130 |
Why?
|
Up-Regulation | 3 | 2008 | 490 | 0.120 |
Why?
|
Adipose Tissue | 2 | 2005 | 167 | 0.120 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 136 | 0.120 |
Why?
|
Treatment Outcome | 2 | 2010 | 1349 | 0.120 |
Why?
|
Base Sequence | 2 | 2006 | 932 | 0.120 |
Why?
|
Carrier Proteins | 2 | 2008 | 287 | 0.120 |
Why?
|
Mice, Transgenic | 2 | 2007 | 608 | 0.120 |
Why?
|
Mice, Inbred mdx | 1 | 2013 | 4 | 0.120 |
Why?
|
Down-Regulation | 2 | 2008 | 420 | 0.110 |
Why?
|
Androgens | 2 | 2004 | 87 | 0.110 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2013 | 9 | 0.110 |
Why?
|
Dystrophin | 1 | 2013 | 19 | 0.110 |
Why?
|
beta-Galactosidase | 2 | 2002 | 34 | 0.110 |
Why?
|
Adenoviridae | 2 | 2002 | 59 | 0.110 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 142 | 0.110 |
Why?
|
Glucocorticoids | 2 | 2003 | 80 | 0.110 |
Why?
|
Electric Stimulation | 2 | 2002 | 177 | 0.110 |
Why?
|
Age Factors | 2 | 2007 | 1007 | 0.110 |
Why?
|
Reactive Oxygen Species | 4 | 2007 | 416 | 0.110 |
Why?
|
Cell Nucleus | 2 | 2005 | 351 | 0.110 |
Why?
|
Nitric Oxide Donors | 1 | 2011 | 18 | 0.100 |
Why?
|
Allopurinol | 1 | 2011 | 11 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 781 | 0.100 |
Why?
|
Xanthine Dehydrogenase | 1 | 2010 | 2 | 0.100 |
Why?
|
MicroRNAs | 1 | 2016 | 386 | 0.100 |
Why?
|
Denervation | 2 | 2007 | 26 | 0.100 |
Why?
|
Penile Implantation | 1 | 2010 | 1 | 0.100 |
Why?
|
Transsexualism | 1 | 2010 | 17 | 0.090 |
Why?
|
Uterine Prolapse | 1 | 2009 | 3 | 0.090 |
Why?
|
Muscle Cells | 1 | 2009 | 12 | 0.090 |
Why?
|
Intestine, Small | 1 | 2009 | 24 | 0.090 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 87 | 0.090 |
Why?
|
Triazines | 2 | 2006 | 19 | 0.090 |
Why?
|
Veins | 1 | 2009 | 7 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 628 | 0.090 |
Why?
|
Kidney Function Tests | 1 | 2009 | 30 | 0.090 |
Why?
|
Enzyme Induction | 1 | 2009 | 48 | 0.090 |
Why?
|
Body Weight | 2 | 2009 | 404 | 0.090 |
Why?
|
Colchicine | 1 | 2008 | 15 | 0.090 |
Why?
|
Tubulin Modulators | 1 | 2008 | 16 | 0.090 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 42 | 0.090 |
Why?
|
Testis | 3 | 2005 | 185 | 0.080 |
Why?
|
Caspase 2 | 1 | 2008 | 6 | 0.080 |
Why?
|
Insulin | 1 | 2010 | 224 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 115 | 0.080 |
Why?
|
Random Allocation | 1 | 2008 | 139 | 0.080 |
Why?
|
Smad Proteins | 1 | 2008 | 12 | 0.080 |
Why?
|
Phosphorylation | 2 | 2008 | 878 | 0.080 |
Why?
|
Follistatin | 1 | 2008 | 27 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 184 | 0.080 |
Why?
|
Video Recording | 1 | 2007 | 32 | 0.080 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 117 | 0.080 |
Why?
|
Lac Operon | 1 | 2006 | 19 | 0.070 |
Why?
|
Stroke Volume | 1 | 2007 | 97 | 0.070 |
Why?
|
Kidney | 1 | 2009 | 322 | 0.070 |
Why?
|
Genes, Reporter | 1 | 2006 | 132 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2007 | 121 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2006 | 30 | 0.070 |
Why?
|
TCF Transcription Factors | 1 | 2005 | 14 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2005 | 20 | 0.070 |
Why?
|
Gene Silencing | 1 | 2006 | 143 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2005 | 18 | 0.070 |
Why?
|
Osteogenesis | 1 | 2005 | 31 | 0.070 |
Why?
|
MyoD Protein | 1 | 2005 | 9 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2005 | 48 | 0.070 |
Why?
|
Osteoblasts | 1 | 2005 | 33 | 0.070 |
Why?
|
Azacitidine | 1 | 2005 | 21 | 0.070 |
Why?
|
Administration, Oral | 1 | 2006 | 212 | 0.070 |
Why?
|
Dexamethasone | 2 | 2003 | 43 | 0.070 |
Why?
|
beta Catenin | 1 | 2005 | 46 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 220 | 0.070 |
Why?
|
Blood Pressure | 1 | 2009 | 613 | 0.070 |
Why?
|
Androstenedione | 1 | 2004 | 16 | 0.070 |
Why?
|
Cell Lineage | 1 | 2005 | 88 | 0.060 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2004 | 8 | 0.060 |
Why?
|
Hypogonadism | 1 | 2004 | 21 | 0.060 |
Why?
|
Germ Cells | 1 | 2005 | 70 | 0.060 |
Why?
|
Xanthine Oxidase | 1 | 2004 | 8 | 0.060 |
Why?
|
DNA Primers | 1 | 2005 | 269 | 0.060 |
Why?
|
Injections | 1 | 2004 | 35 | 0.060 |
Why?
|
Inflammation | 1 | 2009 | 577 | 0.060 |
Why?
|
Urologic Surgical Procedures | 1 | 2004 | 4 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2006 | 528 | 0.060 |
Why?
|
Oxidoreductases | 1 | 2004 | 82 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2003 | 60 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2003 | 20 | 0.060 |
Why?
|
Dihydrotestosterone | 1 | 2003 | 26 | 0.060 |
Why?
|
Middle Aged | 4 | 2006 | 9642 | 0.060 |
Why?
|
Organ Specificity | 1 | 2003 | 123 | 0.060 |
Why?
|
Time Factors | 1 | 2008 | 1681 | 0.060 |
Why?
|
Adult | 5 | 2004 | 11034 | 0.060 |
Why?
|
Disease Progression | 1 | 2005 | 580 | 0.060 |
Why?
|
Pancreatic Elastase | 1 | 2002 | 7 | 0.050 |
Why?
|
Early Growth Response Protein 1 | 1 | 2002 | 10 | 0.050 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2002 | 7 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 160 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2002 | 29 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 555 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2002 | 139 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2002 | 72 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2002 | 100 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2002 | 197 | 0.050 |
Why?
|
Reproduction | 1 | 2002 | 63 | 0.050 |
Why?
|
Ubiquitin | 1 | 2002 | 76 | 0.050 |
Why?
|
RNA | 1 | 2003 | 234 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2002 | 82 | 0.050 |
Why?
|
Expert Testimony | 2 | 2010 | 5 | 0.050 |
Why?
|
Sex Factors | 1 | 2003 | 859 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2010 | 92 | 0.050 |
Why?
|
Rats, Inbred BN | 3 | 2005 | 19 | 0.050 |
Why?
|
Child, Preschool | 1 | 2003 | 1318 | 0.040 |
Why?
|
Prospective Studies | 1 | 2003 | 1353 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2002 | 901 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 522 | 0.040 |
Why?
|
Cytokines | 1 | 2002 | 569 | 0.040 |
Why?
|
Child | 1 | 2003 | 2875 | 0.030 |
Why?
|
Prevalence | 2 | 2010 | 1425 | 0.030 |
Why?
|
3T3 Cells | 2 | 2005 | 58 | 0.030 |
Why?
|
Adolescent | 1 | 2003 | 5035 | 0.030 |
Why?
|
Cell Division | 2 | 2003 | 296 | 0.030 |
Why?
|
Kinetics | 2 | 2004 | 650 | 0.030 |
Why?
|
Aged | 1 | 2003 | 6448 | 0.030 |
Why?
|
Penile Prosthesis | 1 | 2010 | 1 | 0.020 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2010 | 2 | 0.020 |
Why?
|
Amputation, Traumatic | 1 | 2010 | 1 | 0.020 |
Why?
|
Sexology | 1 | 2010 | 1 | 0.020 |
Why?
|
Rupture | 1 | 2010 | 3 | 0.020 |
Why?
|
Replantation | 1 | 2010 | 2 | 0.020 |
Why?
|
Urology | 1 | 2010 | 6 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 2010 | 20 | 0.020 |
Why?
|
Medicine | 1 | 2010 | 31 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 187 | 0.020 |
Why?
|
Patient Selection | 1 | 2010 | 154 | 0.020 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
|
Caspase 9 | 1 | 2008 | 27 | 0.020 |
Why?
|
Aldehydes | 1 | 2008 | 65 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 73 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 139 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 3414 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2006 | 202 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 149 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2004 | 34 | 0.020 |
Why?
|
Protein Transport | 1 | 2005 | 286 | 0.020 |
Why?
|
Reference Values | 1 | 2004 | 204 | 0.020 |
Why?
|
Plasminogen Inactivators | 1 | 2004 | 3 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 2004 | 35 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 210 | 0.020 |
Why?
|
Receptors, Somatotropin | 1 | 2003 | 12 | 0.020 |
Why?
|
Physical Exertion | 1 | 2003 | 25 | 0.020 |
Why?
|
Tosyl Compounds | 1 | 2003 | 2 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2003 | 19 | 0.010 |
Why?
|
Anilides | 1 | 2003 | 27 | 0.010 |
Why?
|
Arteries | 1 | 2004 | 67 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2003 | 98 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 317 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2003 | 66 | 0.010 |
Why?
|
Nitriles | 1 | 2003 | 66 | 0.010 |
Why?
|
Mifepristone | 1 | 2003 | 33 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 2003 | 31 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 423 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 338 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 2002 | 36 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2002 | 49 | 0.010 |
Why?
|
Models, Animal | 1 | 2002 | 131 | 0.010 |
Why?
|
United States | 1 | 2010 | 3894 | 0.010 |
Why?
|
Body Mass Index | 1 | 2003 | 775 | 0.010 |
Why?
|
Gonzalez-Cadavid's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(310)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_